BTBD2 Blocking Peptide (Center)
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9BX70 |
---|---|
Other Accession | NP_060267.2 |
Gene ID | 55643 |
---|---|
Other Names | BTB/POZ domain-containing protein 2, BTBD2 |
Target/Specificity | The synthetic peptide sequence is selected from aa 270-281 of HUMAN BTBD2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | BTBD2 |
---|---|
Cellular Location | Cytoplasm. Note=Localizes to punctate or elongated cytoplasmic bodies |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The C-terminus of the protein encoded by this gene binds topoisomerase I. The N-terminus contains a proline-rich region and a BTB/POZ domain (broad-complex, Tramtrack and bric a brac/Pox virus and Zinc finger), both of which are typically involved in protein-protein interactions. Subcellularly, the protein localizes to cytoplasmic bodies.
References
Olejnik-Schmidt, A.K., et al. Arch. Virol. 153(5):983-990(2008)
Stelzl, U., et al. Cell 122(6):957-968(2005)
Barrios-Rodiles, M., et al. Science 307(5715):1621-1625(2005)
Colland, F., et al. Genome Res. 14(7):1324-1332(2004)
Grimwood, J., et al. Nature 428(6982):529-535(2004)
Xu, L., et al. Exp. Cell Res. 288(1):84-93(2003)
Yamada, A., et al. Cancer Res. 63(11):2829-2835(2003)
Xu, L., et al. BMC Genomics 3 (1), 1 (2002) :
Carim-Todd, L., et al. Gene 262 (1-2), 275-281 (2001) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.